Miragen Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $63M | 3.2M | 19.56 |
| 2025-12-31 | $107M | 3.4M | 31.12 |
| 2025-09-30 | $52M | 2.4M | 21.58 |
| 2025-06-30 | $41M | 2.9M | 13.98 |
| 2025-03-31 | $23M | 1.7M | 13.48 |
| 2024-12-31 | $25M | 1.3M | 19.17 |
| 2024-09-30 | $1.0M | 45k | 22.77 |
| 2024-06-30 | $578k | 44k | 13.01 |
| 2024-03-31 | $550k | 31k | 17.53 |
| 2023-12-31 | $565k | 26k | 21.78 |
| 2023-09-30 | $407k | 27k | 15.34 |
| 2023-06-30 | $570k | 24k | 23.80 |
| 2023-03-31 | $577k | 23k | 25.46 |
| 2022-12-31 | $727k | 25k | 29.20 |